- Home
- CHW vs THW Comparison
CHW vs THW Comparison
Compare CHW & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | CHW | THW |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Finance Companies |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 563.9M | 565.9M |
| IPO Year | 2007 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CHW | THW |
|---|---|---|
| Price | $8.50 | $14.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 133.4K | 116.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.98 | $11.18 |
| 52 Week High | $9.18 | $14.50 |
Technical Indicators
Market Signals| Indicator | CHW | THW |
|---|---|---|
| Relative Strength Index (RSI) | 48.05 | 56.19 |
| Support Level | $8.45 | $12.33 |
| Resistance Level | $8.81 | $14.50 |
| Average True Range (ATR) | 0.10 | 0.22 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 38.75 | 28.62 |
Price Performance
Historical ComparisonAbout CHW Calamos Global Dynamic Income Fund
Calamos Global Dynamic Income Fund operates as a closed-end management investment company. The company's investment objective is to generate a high level of current income with the objective of capital appreciation. It dynamically allocates its investment among equities, convertible bonds, fixed-income securities, and alternative investments.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.